Mesenchymal Cell News

Mesenchymal Cell News is an online resource that delivers updates on the latest research in the mesenchymal stem cell field.

Subscribe|Follow Us On

Endosteal Integrin-α8⁺ Mesenchymal Stem Cells Maintain Hematopoietic Stem Cell Function via Extracellular Matrix-Mediated Interactions

July 7, 2026

[Nature Communications] Scientists identified a distinct subset of MSCs expressing integrin α8 within the bone marrow endosteum. These cells exhibited distinct MSC properties and higher hematopoietic supportive activity than other MSC subsets.

Visible Light Reprograms MSCs and T Cells Into Tumor-Suppressive States via OPN4-Mediated Epigenetic Remodeling

July 7, 2026

[Acta Pharmacologica Sinica] Using mechanical and electrical stimulation as controls, scientists examined optically stimulated MSCs and T cells and their conditioned medium in breast cancer and osteoclast models.

Overcoming Immunological Barriers in MSC-Derived Insulin-Producing Cells through CRISPR-Based Hypoimmunogenic Engineering and Translational Perspectives for Type 1 Diabetes

July 7, 2026

[Stem Cell Reviews and Reports] By integrating insights from T1D immunopathogenesis, MSC biology, genome editing, and translational immunology, the authors propose a framework linking immune engineering with controlled differentiation, functional maturation, and long-term safety evaluation.

A Microgel Bone Marrow Model of Mesenchymal Stromal Cell Paracrine Signaling Supporting Hematopoietic Stem Cell Retention

July 7, 2026

[Acta Biomaterialia] Scientists described a granular biomaterial approach to create a multicellular platform for hematopoietic stem cell (HSC) culture. By seeding HSCs amongst MSC-laden hydrogel microspheres, they established paracrine-mediated interactions between HSCs and hydrogel encapsulated MSCs.

Bioprinted dECM Particles-Laden Microgels Enhance the Mesenchymal Stromal Cell Paracrine Effect for Myocardial Infarction Treatment

July 7, 2026

[Acta Biomaterialia] Researchers developed an integrated microcarrier system via digital light processing, which encapsulates MSCs within microgels functionalized with cardiac-derived decellularized ECM particles.

Mesenchymal Stem Cells Therapy for Intrauterine Adhesions and Endometriosis: Potential, Mechanisms, and Future Directions

July 7, 2026

[FASEB Journal] Scientists summarize current evidence from animal models and clinical studies on the application of MSCs and MSC-derived exosomes in treating Intrauterine adhesions and endometriosis.

SLFN11 Binds DDX1 to Counteract Human Mesenchymal Stem/Stromal Cell Senescence through Inhibition of mTOR/eIF4E Signaling Pathway Activation

July 7, 2026

[Life Sciences] Researchers investigated the protective effect and underlying mechanism of the Schlafen (SLFN) 11 gene against human MSC senescence in vitro.

Hypoxia-Preconditioned Dental Pulp Stem Cells Alleviate Acetaminophen-Induced Liver Failure via Promoting MYC-HIF1A/HIF-1α-BNIP3-Mediated Mitophagy

July 7, 2026

[Autophagy] Researchers demonstrated that 24-h exposure to 1% oxygen significantly enhanced HIF1A/HIF-1α expression in dental pulp stem cells.

Engineered iMSCs Delivering Wild-Type IL-2 Achieve Dose-Sparing Tumor Control via CD25-Dependent CD8 T-Cell Activation

July 7, 2026

[BMC Medicine] The authors found that under low-dose conditions, only iMSCs with IL-2 overexpression—but not unmodified iPSC-derived MSCs or free IL-2 alone—induced robust upregulation of CD25 on CD8+ T cells.

First in Region Innovative Cell Therapy for Synovial Sarcoma

June 23, 2026

[University of Maryland Baltimore] The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center is the first in the Maryland, Delaware, Virginia, and Washington, D.C., region to offer a cell therapy treatment for patients with an advanced type of soft tissue cancer, known as synovial sarcoma.

FDA Fully Approves T-Cell Therapy for Advanced Synovial Sarcoma

June 23, 2026

[Oncology News Central] The US FDA has fully approved afamitresgene autoleucel and expanded its indication to include patients aged 12 years and older with unresectable or metastatic synovial sarcoma whose disease has progressed after chemotherapy.

MiT Fusions, TSC1-TSC2 Divergence, and Stem-Like Programs Reveal Distinct Origins, and Vulnerabilities in PEComa

June 23, 2026

[Nature Communications] Researchers performed comprehensive multi-omic profiling of an unselected perivascular epithelioid cell neoplasm cohort. Transcriptomic analysis defined four subtypes with distinct lineage programs—melanocytic, mesenchymal, or adipogenic—as well as unique mutational patterns and clinical behaviors.

Mesenchymal Cell News covers topics such as the isolation, identification, and culturing conditions of mesenchymal stem cells, as well as their cellular characterization, behavior and differentiation capacities. We also include research that focuses on identifying tissue sources of mesenchymal stem cells and their potential therapeutic applications in regenerative medicine and cellular therapies.